Used primarily as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH), this compound plays a key role in research related to inflammation and pain modulation. It helps stabilize endogenous epoxy fatty acids, which have anti-inflammatory and analgesic properties, making it valuable in studying conditions such as neuropathic pain, inflammatory pain, and other chronic pain states. It has shown efficacy in preclinical models for reducing pain hypersensitivity without the side effects associated with opioids. Additionally, it is used in studies exploring cardiovascular diseases, diabetes-related complications, and neurodegenerative disorders due to its broad anti-inflammatory effects. Its high selectivity and oral bioavailability make it a preferred tool compound in pharmacological research.